Showing 7,300 news articles about Health services & systems

Filters Content type: Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Pharmaceutical industry

Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

Editor's pick
The New York Times
10 May 2019
Global health initiatives

Damaged in Scandal, Head of U.N. AIDS Agency Resigns Suddenly

Editor's pick
New York Times
9 May 2019
PrEP programmes & uptake

Generic HIV prevention drug coming in 2020, Gilead says

Editor's pick
CNBC
9 May 2019
PrEP programmes & uptake

Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

Editor's pick
Breakthepatent.org
9 May 2019
Pharmaceutical industry

Group Of Developed Countries Seek To Delay Italian Proposal On Drug Price Transparency

Editor's pick
Health Policy Watch
7 May 2019
Access to healthcare

Zimbabwean patients on ARV treatment have to take expired medicines

Editor's pick
Daily Maverick
7 May 2019
Pharmaceutical industry

Gilead Sciences Returns to Growth in the First Quarter

Editor's pick
Motley Fool
3 May 2019
PrEP policies & guidelines

How About Letting Nurses Provide PrEP to Patients?

Editor's pick
Contagion Live
3 May 2019
Global health targets

Lesotho On Course to Control HIV

Editor's pick
AllAfrica
3 May 2019
Global health initiatives

NGOs claim victory over US funding cut to South Africa’s HIV programmes

Editor's pick
Medical Brief
2 May 2019
Government, leadership & policy

What Can the United States Learn from Africa about HIV Epidemic Control?

Editor's pick
ICAP
2 May 2019
PrEP policies & guidelines

Gilead: Stop Blocking PrEP

Editor's pick
Act Up Dublin
1 May 2019
Elimination of hepatitis C

NHS trumpets Hep C deal, quietly drops 2025 elimination target after legal row

Editor's pick
pharmaphorum
30 April 2019
Elimination of hepatitis C

NHS England strikes world leading deal to help eliminate hepatitis C

Editor's pick
NHS England
30 April 2019
Injectable & long-acting HIV treatment

ViiV Healthcare submits New Drug Application to US FDA for the first monthly, injectable, two-drug regimen of cabotegravir and rilpivirine

Editor's pick
ViiV press release
29 April 2019
Improving HIV care

In Ethiopia, A Focus on Multi-Month ART Scripting at Scale Pays Off

Editor's pick
ICAP
26 April 2019
Combatting stigma

Rep. Brian Sims on Taking HIV Prevention Drug: 'The Shaming Around PrEP Is Akin to Shaming Women on the Pill'

Editor's pick
Newsweek
26 April 2019
New & experimental HIV treatments

ViiV Healthcare announces CHMP Positive Opinion for Dovato® (dolutegravir/lamivudine) as a once-daily, single-pill, two-drug regimen for the treatment of HIV infection

Editor's pick
ViiV press release
26 April 2019
Transgender people

The largest study involving transgender people is providing long-sought insights about their health

Editor's pick
Nature
25 April 2019
Activism & civil society

How Activists Uncovered CDC's Ownership of Truvada PrEP Patents

Editor's pick
The Body
25 April 2019
Finance & funding

South Africa: Cutting U.S. funding will harm people with HIV most

Editor's pick
Health GAP
25 April 2019
Harm reduction

New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand

Editor's pick
Filter
25 April 2019
Pharmaceutical industry

US: The Justice Department Is Looking Into Gilead’s PrEP Profits

Editor's pick
Out
25 April 2019
Access to healthcare

HIV Medical Providers Strongly Oppose Proposed Changes To Medicare Drug Plan’s “Protected Classes”

Editor's pick
Poz
25 April 2019